Prevalence of class I–III BRAF mutations among 114,662 cancer patients in a large genomic database

BRAF mutations are relatively common in many cancers, particularly melanoma, colorectal cancer, and thyroid cancer and to a lesser extent in lung cancer. These mutations can be targeted by BRAF and MEK inhibitors, which exhibit good clinical activity. There are conflicting reports of the various rel...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Exp Biol Med (Maywood)
Hoofdauteurs: Owsley, Jeff, Stein, Matthew K, Porter, Jason, In, Gino K, Salem, Mohamed, O’Day, Steven, Elliott, Andrew, Poorman, Kelsey, Gibney, Geoffrey, VanderWalde, Ari
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: SAGE Publications 2020
Onderwerpen:
Original Research
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7797994/
https://ncbi.nlm.nih.gov/pubmed/33019809
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1535370220959657
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items